Results 21 to 30 of about 173,723 (245)
Frontiers in Neurology, 2023 BackgroundDifferent screening tools to identify advanced Parkinson’s disease (APD) have emerged in recent years. Among them, wearable medical devices, such as STAT-ON™, have been proposed to help to objectively detect APD.ObjectivesTo analyze the ...
Iria Cabo-Lopez +4 more
doaj +1 more source
Pain and motor complications in Parkinson's disease [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 2006 To study the association of pain with motor complications in 117 patients with Parkinson's disease.Patients were asked to refer any pain they experienced at the time of study and lasting since at least 2 months. Basic parkinsonian signs and motor complications (including motor fluctuations and dyskinesia) were assessed and Unified Parkinson's Disease ...
TINAZZI, Michele +8 more
openaire +3 more sources
Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
Brain Sciences, 2019 Background: Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson’s Disease (PD) patients with a potential benefit on non-motor symptoms (NMS).
Gloria Martí-Andrés +6 more
doaj +1 more source
Nerve Complications after Regional Anesthesia in Foot and Ankle Surgery Avoiding the Popliteal Fossa
Foot & Ankle Orthopaedics, 2022 Category: Ankle; Arthroscopy; Hindfoot; Lesser Toes; Midfoot/Forefoot; Other Introduction/Purpose: Popliteal nerve blocks are a common procedure employed by anesthesiologists to augment intraoperative anesthesia as well as provide postoperative pain ...
Ania Bartholomew +4 more
doaj +1 more source
Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s Disease
Parkinson's Disease, 2022 Identification of individual risk factors for motor complications in Parkinson’s disease (PD) can help to guide personalised medical treatment, particularly since treatment options are still limited.
Matthias Löhle +9 more
doaj +1 more source
Motor complications in an incident Parkinson's disease cohort [PDF]
European Journal of Neurology, 2015 Background and purposeLevodopa treatment in Parkinson's disease (PD) causes motor fluctuations and dyskinesias, but few data describe their development or severity in unselected incident cohorts.MethodsDemographic, clinical, treatment, smoking, caffeine and alcohol data from 183 people with PD were gathered from the Parkinsonism Incidence in Northeast ...
Scott, N. W. +2 more
openaire +3 more sources
Parkinson's Disease, 2020 Objective. Motor complications are common in Parkinson’s disease (PD). The reported occurrence of motor complications varies across regions and races.
Baihua Sun +3 more
doaj +1 more source
Neuropsychiatric Disease and Treatment, 2023 Nbaa Masood, Joohi Jimenez-Shahed Department of Neurology, Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York, NY, USACorrespondence: Joohi Jimenez-Shahed, Associate Professor of Neurology & Neurosurgery, Icahn School of Medicine at ...
Masood N, Jimenez-Shahed J
doaj
Imaging of dopamine in PD and implications for motor and neuropsychiatric manifestations of PD
Frontiers in Neurology, 2013 Parkinson’s disease (PD) is characterized by dopamine depletion in the putamen, which leads to motor dysfunction. As the disease progresses, a substantial degree of dopamine depletion also occurs in caudate and nucleus accumbens.
Raul ede la Fuente-Fernandez
doaj +1 more source
Predictive factors for complications after surgical treatment for schwannomas of the extremities
BMC Musculoskeletal Disorders, 2019 Background Schwannomas are well-encapsulated, benign neoplasms, and enucleation is a standard operation procedure. The incidence of neurological complications after surgical treatment for schwannomas of the extremities varies, and there is no consensus ...
Toshihide Hirai +13 more
doaj +1 more source